MTCH
62
22
JNPR
59
3
BK
60
2
CF
47
5
TGNA
48
5
A
43
2
FE
34
4
HBAN
47
7
OXY
42
17
CTAS
36
8
DLTR
52
8
WU
26
2
KHC
11
2
DNB
72
4
L
54
5
NWL
48
4
PLD
35
5
MCO
67
3
OKE
61
2
CAG
34
3
MTCH
62
22
JNPR
59
3
BK
60
2
CF
47
5
TGNA
48
5
A
43
2
FE
34
4
HBAN
47
7
OXY
42
17
CTAS
36
8
DLTR
52
8
WU
26
2
KHC
11
2
DNB
72
4
L
54
5
NWL
48
4
PLD
35
5
MCO
67
3
OKE
61
2
CAG
34
3
Financhill
Back

ANI Pharmaceuticals Quote, Financials, Valuation and Earnings

The 7 new tech giants dominating today's markets

Get Your Copy of "These 7 Stocks Will Be Magnificent in 2025" Here.
Sell
21

ANIP
ANI Pharmaceuticals

Last Price:
$53.38
Seasonality Move:
15.88%

7 Day Trial

ALL ACCESS PASS

$ 7

Elon Musk Predicts MAJOR Crisis in Trump's First Year

See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.

ANI Pharmaceuticals Price Quote

$53.38
-0.01 (-1.62%)
(Updated: December 21, 2024 at 5:14 AM ET)

ANI Pharmaceuticals Key Stats

Sell
21
ANI Pharmaceuticals (ANIP) is a Sell
Day range:
$53.00 - $54.56
52-week range:
$52.00 - $70.81
Dividend yield:
0%
P/E ratio:
62.81
P/S ratio:
1.86
P/B ratio:
2.76%
Volume:
1M
Avg. volume:
302.8K
1-year change:
2.03%
Market cap:
$1.1B
Revenue:
$486.8M
EPS:
$-0.57

How Much Does ANI Pharmaceuticals Make?

Data Unavailable

Is ANI Pharmaceuticals Growing As A Company?

Data Unavailable

ANI Pharmaceuticals Stock Price Performance

What Is ANI Pharmaceuticals 52-Week High & Low?

ANI Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy ANI Pharmaceuticals?

Data Unavailable

Is ANI Pharmaceuticals Cash Flow Positive?

Data Unavailable

ANI Pharmaceuticals Return On Invested Capital

Data Unavailable

ANI Pharmaceuticals Earnings Date & Stock Price

ANI Pharmaceuticals Competitors

  • Who Are ANI Pharmaceuticals's Competitors?
    Below is a list of companies who compete with ANI Pharmaceuticals or are related in some way:
    • AIM ImmunoTech Inc (AIM)
    • Allogene Therapeutics Inc (ALLO)
    • Armata Pharmaceuticals Inc (ARMP)
    • Protalix BioTherapeutics Inc (PLX)
    • Windtree Therapeutics Inc (WINT)

ANI Pharmaceuticals Dividend Yield

Data Unavailable

ANI Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 1266.67% 23.39%
Revenue: 12.52% 2.74%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable